- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
Following the news that Google has unveiled its Pixel 8 series of smartphones; Anisha Bhatia, Senior Technology Analyst at GlobalData, a leading data and analytics company, offers her view: “Google will offer seven years of security and OS updates on its new Pixel 8 series of smartphones. This is longer than what Android rival Samsung […]
Positive US JOLTS for August a blip, real-time data points to much weaker NFP for September, says GlobalData
The US Bureau of Labor Statistics’ Job Openings and Labor Turnover Survey (JOLTS) for August 2023 revealed a surprising increase in job openings to 9.1 million, surpassing the consensus estimate of 8.8 million. Markets took this as a signal of strong economy and increased pressure on US Fed, which closely monitors JOLTS data for signs […]
Steatosis-associated fibrosis estimator algorithm offers hope for early detection and management of NAFLD/NASH, says GlobalData
A novel diagnostic tool, the steatosis-associated fibrosis estimator (SAFE) algorithm, may revolutionize the early detection of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). NAFLD, a common liver condition, often remains undiagnosed until advanced stages. The SAFE algorithm offers promising potential to enhance patient identification, enabling proactive healthcare interventions and alleviating the burden on […]
Insomnia treatment market faces need for innovation as Z-drugs show limitations, says GlobalData
Benzodiazepine-like Z-drugs have dominated the insomnia pharmacological treatment market for the past 30 years. However, due to their unfavorable side effect profile, there is a need for additional treatment options. There are currently four Phase III products in development for the treatment of insomnia. However, they do not possess novel mechanisms of action (MOA) that […]
Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain, says GlobalData
Novo Nordisk‘s obesity medication Wegovy (semaglutide) will soon be accessible through the National Health Service (NHS) in England, albeit with limited supply. To maintain controlled distribution, the National Institute for Health and Clinical Excellence (NICE) will implement eligibility criteria, focusing on patients with comorbidities and specific BMI ranges. Although expected to become a leading obesity […]
China’s Fabry disease treatment gap calls for innovation and collaboration, says GlobalData
The current treatment landscape for Fabry disease in China is completely dependent on enzyme replacement therapies (ERTs) developed by western companies like Sanofi (Fabrazyme) and Takeda (Replagal). Due to the limited affordability of these therapies, there exists a substantial unmet clinical need that could be addressed by newer therapies. However, only a few western innovator […]
European challenger altnets continue to intensify competition against incumbent telcos, finds GlobalData
In a fragmented and dynamic European enterprise telecoms market, alternative service providers, known as “altnets,” continue to grow even as competition intensifies, reveals GlobalData, a leading data and analytics company. Robert Pritchard, Principal Analyst for Enterprise Technology and Services at GlobalData, says: “In turbulent times like these, where former national telcos are largely focused on […]
Alternative payments account for nearly 60% of e-commerce market in India, reveals GlobalData
Alternative payment methods such as mobile and digital wallets completely dominate the e-commerce space in India. They have displaced cash and cards and are the most popular online payment method with 58.1% market share in 2023, finds GlobalData, a leading data and analytics company. An analysis of GlobalData’s E-Commerce Analytics reveals that India’s e-commerce market […]
Apple job postings in August 2023: China second only to US, finds GlobalData
Apple Inc reported a month-on-month uptick in job postings in August 2023. This surge in recruitment comes at the time when news are doing the rounds that the tech giant strives to diversify its supply chain and expand into the Indian market. Despite these endeavors, China ranks second only to the US in terms of job […]
Americas shows marginal improvement in investor risk during Q2 2023, reveals GlobalData
The Americas region experienced a minor decline in its risk score from 47.0 out of 100 in Q1 2023 to 45.8 in Q2 2023 in the GlobalData Country Risk Index (GCRI). This shift was primarily driven by reduced inflationary pressures and an improving labor market, reveals GlobalData, a leading data and analytics company. However, despite […]
VC funding in India startups down by 71.5% YoY to $4.9 billion during January-August 2023, reveals GlobalData
India’s startup-focused venture capital (VC) funding space underwent significant changes in the first eight months of 2023. During this period, 734 VC funding deals were announced, amassing a total of $4.9 billion. While there was a year-on-year (YoY) decrease in both deal volume and value compared to the same period in 2022, the decline was […]
Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData
The acquisition of Intercept Pharmaceuticals by the Italian pharmaceutical company Alfasigma became inevitable due to the failed development of Intercept’s flagship asset, obeticholic acid, as a treatment for non-alcoholic steatohepatitis (NASH). With no advanced assets left in its pipeline and rapidly declining share prices, Intercept had a compelling reason to pursue acquisition, says GlobalData, a […]
Meta Quest 3 brings affordability to XR headsets, says GlobalData
Following the news that Meta has unveiled a new Quest 3 mixed reality (XR) headset; Anisha Bhatia, Senior Analyst at GlobalData, a leading data and analytics company, offers her view: “Quest 3 scores over Apple’s Vision Pro with the absence of tethering. There is no battery pack that needs to be attached nor a wire […]
GlobalData highlights importance of World Contraception Day in promoting patient education and choice in female contraception
September 26 marks World Contraception Day across the world. An essential gap in the realm of female contraception revolves around educating patients about the diverse contraceptive options at their disposal. World Contraception Day plays a vital role in promoting awareness regarding available contraceptive methods, empowering young individuals to make well-informed decisions regarding their sexual health, […]
Apple iPhone 15 ignites diverse social media reactions, finds GlobalData
Apple Inc has recently unveiled the much-awaited iPhone 15 and its pro series during annual fall event. This excitement translated into a notable increase in social media discussions during the second half of September. Among the social media contributors (Reddit.com and X.com), there is a divergence of opinions regarding the smartphone. While some are enamored […]
China venture capital funding down by 30.1% YoY to $26.8 billion in January-August 2023, finds GlobalData
China’s venture capital (VC) funding landscape in the first eight months of 2023 showed a significant slowdown compared to the same period in 2022, with 2,111 VC funding deals amounting to $26.8 billion. This marked an 18.3% drop in deal volume and a 30.1% decrease in disclosed funding value. While this decline aligned with global […]
China pulls down APAC IPO activity in first eight months of 2023, reveals GlobalData
The Asia-Pacific (APAC) initial public offerings (IPOs) market has continued to grapple with disruptions, including the lingering impact of COVID-19, the Russia-Ukraine conflict, rising inflation, and geopolitical tensions. In the first eight months of 2023, APAC saw a significant decline in IPO activity, with 491 listings totaling $44.4 billion, down by 55.9% compared to the […]
Eisai Leqembi approval brings first anti-amyloid treatment to Japan market, says GlobalData
Following the news that Japan’s health ministry has approved Eisai’s intravenous formulation of lecanemab, branded as Leqembi, for use in Alzheimer’s disease; Barbora Salcman, Neurology Analyst at GlobalData, offers her view: “The approval of Leqembi in Japan comes nearly 10 months after the drug was filled for the priority review in January 2023, making it […]
Asia-Pacific Q2 2023 risk decline masked by economic challenges in China, reports GlobalData
The Asia-Pacific (APAC) region exhibited a decline in its overall risk score during the second quarter (Q2) of 2023, dropping from 42.4 in Q1 to 41.7, establishing itself as the second-lowest risk region globally, per the Q2 2023 GlobalData Country Risk Index (GCRI). However, a rising economic parameter risk score signals ongoing challenges within the […]
New generics in idiopathic pulmonary fibrosis space will provide more access to patients, says GlobalData
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments which are available globally, Roche’s Esbriet/Pirespa (pirfenidone) and Boehringer Ingelheim’s (BI) Ofev (nintedanib), which were both approved by the FDA in 2014. Since the patent expiration of Esbriet in 2021, new generic versions have begun entering the IPF space providing more […]